Clinical Trial Update: Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer [Phase 2]

View source ↗

Summary

Phase II study evaluating GemOX hepatic arterial infusion combined with lenvatinib and toripalimab for advanced unresectable intrahepatic cholangiocarcinoma and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gallbladder Cancer
• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Lenvatinib (lenvatinib)
• OXALIPLATIN (Oxaliplatin)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Intrahepatic Cholangiocarcinoma (Icc), Gall Bladder Cancer | Phase 2 | Status: RECRUITING